David Shultz, MD, PhD, of the Princess Margaret Cancer Centre in Toronto, Ontario, Canada, has been awarded the 2018 Hitachi Healthcare Americas /RSNA Research Seed Grant by the RSNA Research & Education (R&E) Foundation.
The one-year, $40,000 grant will allow Shultz to study FAZA-PET/MRI and determine if hypoxia imaging with PET/MRI improves the management of sarcoma. The goal is to ultimately advance a provider's ability to treat patients with high-risk sarcoma.
“The R&E Foundation is grateful for Hitachi Healthcare Americas’ support of the 2018 grant recipients,” said N. Reed Dunnick, MD, chair of the R&E Foundation Board of Trustees, in a prepared statement issued by RSNA. “This longstanding partnership and commitment is a vital component in ensuring research innovation and seeding the future of radiology.”